Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 3

Results: 17

Acknowledgement to reviewers.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 495, doi. 10.1007/s00262-020-02505-y
Publication type:
Article
Retraction Note to: Bio‑HMGB1 from breast cancer contributes to M‑MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC‑like cells.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 493, doi. 10.1007/s00262-020-02489-9
By:
- Su, Zhaoliang;
- Ni, Ping;
- She, Peng;
- Liu, Yueqin;
- Richard, Seidu A.;
- Xu, Wenlin;
- Zhu, Haitao;
- Wang, Jia
Publication type:
Article
PCSK9 is a promising prognostic marker in patients with advanced NSCLC.
Published in:
2020
By:
- Bonaventura, Aldo;
- Grossi, Francesco;
- Montecucco, Fabrizio
Publication type:
Letter
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 449, doi. 10.1007/s00262-020-02480-4
By:
- Thomas, Remy;
- Shaath, Hibah;
- Naik, Adviti;
- Toor, Salman M.;
- Elkord, Eyad;
- Decock, Julie
Publication type:
Article
The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 465, doi. 10.1007/s00262-020-02479-x
By:
- Quan, Hongzhi;
- Shan, Zhongyan;
- Liu, Ziyi;
- Liu, Sixuan;
- Yang, Liu;
- Fang, Xiaodan;
- Li, Kun;
- Wang, Baisheng;
- Deng, Zhiyuan;
- Hu, Yanjia;
- Yao, Zhigang;
- Huang, Junhui;
- Yu, Jianjun;
- Xia, Kun;
- Tang, Zhangui;
- Fang, Liangjuan
Publication type:
Article
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 421, doi. 10.1007/s00262-019-02477-8
By:
- Sarkar, Subhashis;
- Chauhan, Sachin K. S.;
- Daly, John;
- Natoni, Alessandro;
- Fairfield, Heather;
- Henderson, Robert;
- Nolan, Emma;
- Swan, Dawn;
- Hu, Jinsong;
- Reagan, Michaela R.;
- O'Dwyer, Michael
Publication type:
Article
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 435, doi. 10.1007/s00262-019-02472-z
By:
- Bergenfelz, Caroline;
- Roxå, Anna;
- Mehmeti, Meliha;
- Leandersson, Karin;
- Larsson, Anna-Maria
Publication type:
Article
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 477, doi. 10.1007/s00262-019-02466-x
By:
- Boudewijns, Steve;
- Bloemendal, Martine;
- de Haas, Nienke;
- Westdorp, Harm;
- Bol, Kalijn F.;
- Schreibelt, Gerty;
- Aarntzen, Erik H. J. G.;
- Lesterhuis, W. Joost;
- Gorris, Mark A. J.;
- Croockewit, Alexandra;
- van der Woude, Lieke L.;
- van Rossum, Michelle M.;
- Welzen, Marieke;
- de Goede, Anna;
- Hato, Stanleyson V.;
- van der Graaf, Winette T. A.;
- Punt, Cornelis J. A.;
- Koornstra, Rutger H. T.;
- Gerritsen, Winald R.;
- Figdor, Carl G.
Publication type:
Article
Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 407, doi. 10.1007/s00262-019-02464-z
By:
- Roussel, Mikael;
- Lhomme, Faustine;
- Roe, Caroline E.;
- Bartkowiak, Todd;
- Gravelle, Pauline;
- Laurent, Camille;
- Fest, Thierry;
- Irish, Jonathan M.
Publication type:
Article
Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 399, doi. 10.1007/s00262-019-02462-1
By:
- Zhang, Guowei;
- Cheng, Ruirui;
- Wang, Huijuan;
- Zhang, Yong;
- Yan, Xiangtao;
- Li, Peng;
- Zhang, Mina;
- Zhang, Xiaojuan;
- Yang, Jinpo;
- Niu, Yuanyuan;
- Ma, Zhiyong
Publication type:
Article
The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 325, doi. 10.1007/s00262-019-02461-2
By:
- Patel, Akshay J.;
- Richter, Alex;
- Drayson, Mark T.;
- Middleton, Gary W.
Publication type:
Article
Lung cancer-derived extracellular vesicles: a possible mediator of mast cell activation in the tumor microenvironment.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 373, doi. 10.1007/s00262-019-02459-w
By:
- Salamon, Pazit;
- Mekori, Yoseph A.;
- Shefler, Irit
Publication type:
Article
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 355, doi. 10.1007/s00262-019-02458-x
By:
- Bains, Simer J.;
- Abrahamsson, Hanna;
- Flatmark, Kjersti;
- Dueland, Svein;
- Hole, Knut H.;
- Seierstad, Therese;
- Redalen, Kathrine Røe;
- Meltzer, Sebastian;
- Ree, Anne Hansen
Publication type:
Article
Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 383, doi. 10.1007/s00262-019-02456-z
By:
- Battaglia, Alessandra;
- Buzzonetti, Alexia;
- Fossati, Marco;
- Scambia, Giovanni;
- Fattorossi, Andrea;
- Madiyalakan, Madi R.;
- Mahnke, Yolanda D.;
- Nicodemus, Christopher
Publication type:
Article
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 343, doi. 10.1007/s00262-019-02453-2
By:
- Wilson, Brooke E.;
- Routy, Bertrand;
- Nagrial, Adnan;
- Chin, Venessa T.
Publication type:
Article
Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2020, v. 69, n. 3, p. 365, doi. 10.1007/s00262-019-02452-3
By:
- Ma, Junxun;
- Sun, Danyang;
- Wang, Jinliang;
- Han, Chun;
- Qian, Yuanyu;
- Chen, Guangying;
- Li, Xiaoyan;
- Zhang, Juan;
- Cui, Pengfei;
- Du, Wushuang;
- Wu, Zhaozhen;
- Chen, Shixue;
- Zheng, Xuan;
- Yue, Zhichao;
- Song, Jia;
- Gao, Chan;
- Cai, Shangli;
- Hu, Yi
Publication type:
Article
PD-L1 expression levels should be considered when identifying risk factors in NSCLC patients treated with nivolumab.
Published in:
2020
By:
- Li, Pengfei;
- Che, Guowei
Publication type:
Letter